Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing growth hormone replacement therapy in veterans with adult growth hormone deficiency and mild traumatic brain injury; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Growth hormone replacement therapy (somatropin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Adult Growth Hormone Deficiency, Mild Traumatic Brain Injury | Phase 3 | Status: RECRUITING